Drug intelligence / Profile preview

Premens

Development stage
Phase 3
Lead developer
Max Zeller Söhne
Modality
Small Molecules
Administration
Oral
01

Overview

Premens is a medical herbal product developed by Max Zeller Söhne AG (Zeller Medical AG) for the treatment of premenstrual syndrome (PMS) and menstrual cycle disturbances. The active ingredient is a dry extract of *Vitex agnus-castus* (chaste tree) fruit, with each film-coated tablet containing 20 mg of the extract. Premens is indicated for both physical and psychological symptoms of PMS, including breast tension (mastodynia), mood swings, irritability, and headaches. Its primary mechanism of action involves dopaminergic activity; constituents of the extract act as agonists at dopamine D2 receptors in the anterior pituitary, which inhibits the secretion of prolactin. This reduction in prolactin levels helps address latent hyperprolactinemia, a common underlying factor in PMS symptoms. The product is approved and marketed in Switzerland as a medicinal herbal preparation.

Brand names
PremensZeller Medical PreMens
Other names
Vitex agnus-castus extractChaste tree extractMonk's pepper extract
02

Targets

DRD2 (Dopamine D2 Receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on Premens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Premens.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call